Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

200 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Drug Effects on the Thyroid.
Angus L, Peeters RP, van der Veldt AAM. Angus L, et al. Among authors: van der veldt aam. N Engl J Med. 2019 Nov 14;381(20):1980. doi: 10.1056/NEJMc1912672. N Engl J Med. 2019. PMID: 31722168 No abstract available.
Validation of a clinicopathological and gene expression profile model for sentinel lymph node metastasis in primary cutaneous melanoma.
Mulder EEAP, Dwarkasing JT, Tempel D, van der Spek A, Bosman L, Verver D, Mooyaart AL, van der Veldt AAM, Verhoef C, Nijsten TEC, Grunhagen DJ, Hollestein LM. Mulder EEAP, et al. Among authors: van der spek a, van der veldt aam. Br J Dermatol. 2021 May;184(5):944-951. doi: 10.1111/bjd.19499. Epub 2020 Nov 2. Br J Dermatol. 2021. PMID: 32844403 Free PMC article.
Early discontinuation of PD-1 blockade upon achieving a complete or partial response in patients with advanced melanoma: the multicentre prospective Safe Stop trial.
Mulder EEAP, de Joode K, Litière S, Ten Tije AJ, Suijkerbuijk KPM, Boers-Sonderen MJ, Hospers GAP, de Groot JWB, van den Eertwegh AJM, Aarts MJB, Piersma D, van Rijn RS, Kapiteijn E, Vreugdenhil G, van den Berkmortel FWPJ, Hoop EO, Franken MG, Ryll B, Rutkowski P, Sleijfer S, Haanen JBAG, van der Veldt AAM. Mulder EEAP, et al. Among authors: van den eertwegh ajm, van der veldt aam, van den berkmortel fwpj, van rijn rs. BMC Cancer. 2021 Mar 25;21(1):323. doi: 10.1186/s12885-021-08018-w. BMC Cancer. 2021. PMID: 33765967 Free PMC article.
False positive FDG uptake in melanoma patients treated with talimogene laherparepvec (T-VEC).
Mulder EEAP, Stahlie EHA, Verver D, Lemstra C, Been LB, Mooyaart AL, Brabander T, Vegt E, Verburg FA, van der Veldt AAM, Verhoef C, van Akkooi ACJ, Grünhagen DJ. Mulder EEAP, et al. Among authors: van akkooi acj, van der veldt aam. J Surg Oncol. 2021 Dec;124(7):1161-1165. doi: 10.1002/jso.26607. Epub 2021 Jul 8. J Surg Oncol. 2021. PMID: 34235758 Free PMC article.
Adjuvant treatment in patients with melanoma: The planning of scanning.
Mulder EEAP, Grünhagen DJ, Sleijfer S, Uyl-de Groot CA, van der Veldt AAM. Mulder EEAP, et al. Among authors: van der veldt aam. Eur J Cancer. 2021 Nov;157:306-307. doi: 10.1016/j.ejca.2021.08.041. Epub 2021 Sep 21. Eur J Cancer. 2021. PMID: 34555650 No abstract available.
Mesenchymal-epithelial transition factor (MET) immunoreactivity in positive sentinel nodes from patients with melanoma.
Mulder EEAP, Verver D, van der Klok T, de Wijs CJ, van den Bosch TPP, De Herdt MJ, van der Steen B, Verhoef C, van der Veldt AAM, Grünhagen DJ, Koljenovic S. Mulder EEAP, et al. Among authors: van der klok t, van der veldt aam, van den bosch tpp, van der steen b. Ann Diagn Pathol. 2022 Jun;58:151909. doi: 10.1016/j.anndiagpath.2022.151909. Epub 2022 Feb 7. Ann Diagn Pathol. 2022. PMID: 35151198 Free article.
Histopathological and immunological spectrum in response evaluation of talimogene laherparepvec treatment and correlation with durable response in patients with cutaneous melanoma.
Mulder EEAP, Damman J, Verver D, van der Veldt AAM, Tas S, Khemai-Mehraban T, Heezen KC, Wouters RA, Verhoef C, Verjans GMGM, Langerak AW, Grünhagen DJ, Mooyaart AL. Mulder EEAP, et al. Among authors: van der veldt aam. Melanoma Res. 2022 Aug 1;32(4):249-259. doi: 10.1097/CMR.0000000000000824. Epub 2022 Apr 21. Melanoma Res. 2022. PMID: 35446267 Free PMC article.
Using a Clinicopathologic and Gene Expression (CP-GEP) Model to Identify Stage I-II Melanoma Patients at Risk of Disease Relapse.
Mulder EEAP, Johansson I, Grünhagen DJ, Tempel D, Rentroia-Pacheco B, Dwarkasing JT, Verver D, Mooyaart AL, van der Veldt AAM, Wakkee M, Nijsten TEC, Verhoef C, Mattsson J, Ny L, Hollestein LM, Olofsson Bagge R. Mulder EEAP, et al. Among authors: van der veldt aam. Cancers (Basel). 2022 Jun 9;14(12):2854. doi: 10.3390/cancers14122854. Cancers (Basel). 2022. PMID: 35740520 Free PMC article.
200 results